| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Team Building > Finding Time by Clearing Crisis Clutter - 7 Tips to Handle Crisis Junkies and Safeguard Your Time |
|
Digg It - Finding Time by Clearing Crisis Clutter - 7 Tips to Handle Crisis Junkies and Safeguard Your Time
Finding time to do your most rewarding work? What happens when strong personalities make demands on you? Your colleagues may regularly confront you with ' According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product surprise' deadlines or crises. If you are not careful, they can easily sabotage your plans for your time. How do you withstand others' crises without enda ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ngering your job and your professional relationships? 7 Proven Tips to Stay on Track, Strengthen Relationships and Save Time
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. o be swept along by others' urgency. Urgency is a key weapon of strong personalities. Do not make their crisis your crisis. By taking ti here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe me to carefully consider your response, you demonstrate that you retain full responsibility for yourself. E d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro xamine your level of responsibility for the problem, and your stake in the outcome. With this overview, you can decide how much time to devote %u2013 if an ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc y - to solving their problem! By re-stating their predicament in your own words, easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi you re-frame the incident, and also:
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically less highly charged terms. and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ as. Strategizing from multiple vantage points reduces the tunnel vision that urgency promotes. Identify areas of ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi consensus. You can empathize while retaining a balanced view. Succeed through identifying ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a everyone's baseline needs and negotiate accordingly. Clearly state your parameters, so that your own projects remain on schedule. dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod r responses. This may be the hardest part for you. Cultivate calmness so you can accept others' dissatisfaction without defensiveness. This demonstrat cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin es you respect their right to their feelings and that your time priorities don't require their approval. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen rol. Take the time to clarify your end of relationships. Specify what you feel comfortable doing, and the amount of time you are willing to spend doin t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel g it. By being clear, you encourage open communication that can lead to genuine progress.
Assimilating this in advance is excellent preparati ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust on. Your relationships are often unspoken contracts. As you change your part, prepare yourself for other aspects of interactions to shift, For example, as y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products you become less available at the last-minute, others may be asked to help. Or you may be called upon to coordinate schedules and priorities more closely wi . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de th colleagues. This might shake up your image of yourself as indispensable, or your image of others as 'impossible'. Ultimately, with skillful negotiating elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip , you benefit by enjoying more productive, crisis-free time. How will you build on your success by developing still more rewarding methods for finding time tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Five Things to Do while Waiting for a Job Interview A Hot Business for 2006: Non-Medical Home Care Business The Difference Between Moving Bolts and Moving People
|